Skip to main content

Table 1 Antitumor activity of TW-37 in WSU-DLCL2 bearing SCID mice.

From: SMI of Bcl-2 TW-37 is active across a spectrum of B-cell tumors irrespective of their proliferative and differentiation status

Agent* No. of Animals T/C (%) T-C (days) Log10 Kill (Gross)
Control 5 0.0 0 22 0.0
TW-37 5 28 10 1.5
  1. *TW-37 was given at its MTD; 40 mg/kg × 3 days, via tail vein.